Terkko Navigator / Lemström, K(arl)*

Monogenic gene variants in lung transplant recipients with usual interstitial pneumonia

Cancer risk and mortality after solid organ transplantation - A population-based 30-year cohort study in Finland

Failing Heart Transplants and Rejection-A Cellular Perspective

Plasma proteome of brain-dead organ donors predicts heart transplant outcome

Inhibition of VEGF-receptors 1 and 2 attenuates NK cell and innate immune responses in an experimental model for obliterative bronchiolitis

Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion

COVID-19 pandemic and worldwide organ transplantation: a population-based study

Epitranscriptomics of Ischemic Heart Disease-The IHD-EPITRAN Study Design and Objectives

Randomised sham-controlled double-blind trial evaluating remote ischaemic preconditioning in solid organ transplantation: a study protocol for the RIPTRANS trial

Corrigendum to 'Extracorporeal membrane oxygenation for refractory cardiogenic shock: patient survival and health-related quality of life'  [Eur J Cardiothorac Surg 2019;55:780-787]

Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial

Outcome of patients receiving a continuous flow left ventricular assist device - a retrospective single center study

Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience

Cost-utility of venoarterial extracorporeal membrane oxygenation in cardiogenic shock and cardiac arrest

Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy

Donor Simvastatin Treatment in Heart Transplantation

Cancer incidence and mortality after heart transplantation - A population-based national cohort study

Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictors

Extracorporeal membrane oxygenation for refractory cardiogenic shock: patient survival and health-related quality of life

Hypoxia-inducible factor controls immunoregulatory properties of myeloid cells in mouse cardiac allografts - an experimental study

Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin

Propranolol for gastrointestinal bleeding in two patients with continuous flow left ventricle assist device

Vascular Endothelial Growth Factor-B Overexpressing Hearts Are Not Protected From Transplant-Associated Ischemia-Reperfusion Injury

Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury

Simvastatin Treatment Upregulates Anti-Fibrotic Bone Morphogenetic Protein-7 Expression at Rat Cardiac Allograft Rejection

High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma

Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion

Decreased maximum clot firmness in rotational thromboelastometry (ROTEM®) is associated with bleeding during extracorporeal mechanical circulatory support

Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse

Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts

Platelet-derived Growth Factor-B Protects Rat Cardiac Allografts From Ischemia-reperfusion Injury

VEGF Pathways in the Lymphatics of Healthy and Diseased Heart

Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts

Donor Heart Treatment With COMP-Ang1 Limits Ischemia-Reperfusion Injury and Rejection of Cardiac Allografts

Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts

Ex vivo intracoronary gene transfer of adeno-associated virus 2 leads to superior transduction over serotypes 8 and 9 in rat heart transplants

Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function

Combined donor simvastatin and methylprednisolone treatment prevents ischemia-reperfusion injury in rat cardiac allografts through vasculoprotection and immunomodulation

Differential effects of pharmacological HIF preconditioning of donors versus recipients in rat cardiac allografts

Donor simvastatin treatment and cardiac allograft ischemia/reperfusion injury

Three decades of heart transplantation in Scandinavia: long-term follow-up

Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis

Effect of simvastatin on development of obliterative airway disease: an experimental study

Application of extracorporeal membrane oxygenation therapy (ECMO) in the treatment of severe adult respiratory distress syndrome

Mechanical support for the heart and circulation in adults

Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection

Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts

Control of early Aspergillus mortality after lung transplantation: outcome and risk factors

Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation

Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study